External validation of Fetal Medicine Foundation competing‐risks model for midgestation prediction of small‐for‐gestational‐age neonates in Spanish population

Author:

Albaiges G.1ORCID,Papastefanou I.23ORCID,Rodriguez I.4,Prats P.1,Echevarria M.1,Rodriguez M. A.1,Rodriguez Melcon A.1

Affiliation:

1. Fetal Medicine Unit, Obstetrics Service, Department of Obstetrics, Gynecology and Reproductive Medicine University Hospital Quirón Dexeus Barcelona Spain

2. Fetal Medicine Research Institute King's College Hospital London UK

3. Department of Women and Children's Health Faculty of Life Sciences and Medicine, King's College London London UK

4. Epidemiological Unit, Department of Obstetrics, Gynecology and Reproductive Medicine University Hospital Quiron Dexeus Barcelona Spain

Abstract

ABSTRACTObjectiveTo examine the external validity of the new Fetal Medicine Foundation (FMF) competing‐risks model for prediction in midgestation of small‐for‐gestational‐age (SGA) neonates.MethodsThis was a single‐center prospective cohort study of 25 484 women with a singleton pregnancy undergoing routine ultrasound examination at 19 + 0 to 23 + 6 weeks' gestation. The FMF competing‐risks model for the prediction of SGA combining maternal factors and midgestation estimated fetal weight by ultrasound scan (EFW) and uterine artery pulsatility index (UtA‐PI) was used to calculate risks for different cut‐offs of birth‐weight percentile and gestational age at delivery. The predictive performance was evaluated in terms of discrimination and calibration.ResultsThe validation cohort was significantly different in composition compared with the FMF cohort in which the model was developed. In the validation cohort, at a 10% false‐positive rate (FPR), maternal factors, EFW and UtA‐PI yielded detection rates of 69.6%, 38.7% and 31.7% for SGA < 10th percentile with delivery at < 32, < 37 and ≥ 37 weeks' gestation, respectively. The respective values for SGA < 3rd percentile were 75.7%, 48.2% and 38.1%. Detection rates in the validation cohort were similar to those reported in the FMF study for SGA with delivery at < 32 weeks but lower for SGA with delivery at < 37 and ≥ 37 weeks. Predictive performance in the validation cohort was similar to that reported in a subgroup of the FMF cohort consisting of nulliparous and Caucasian women. Detection rates in the validation cohort at a 15% FPR were 77.4%, 50.0% and 41.5% for SGA < 10th percentile with delivery at < 32, < 37 and ≥ 37 weeks, respectively, which were similar to the respective values reported in the FMF study at a 10% FPR. The model had satisfactory calibration.ConclusionThe new competing‐risks model for midgestation prediction of SGA developed by the FMF performs well in a large independent Spanish population. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

Publisher

Wiley

Subject

Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Reproductive Medicine,General Medicine,Radiological and Ultrasound Technology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Prediction of adverse perinatal outcome at midgestation;Ultrasound in Obstetrics & Gynecology;2023-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3